BEIJING: Recently, KFSN, an ABC affiliate, aired a news report: the Clinical Skills and Simulation Center at UCSF Fresno has received a new batch of point-of-care (POC) ultrasound devices — the TEX20 series. Mindray, the company that developed the medical devices, is headquartered in Shen-zhen, South China’s Guangdong Province.
Compact and versatile, these ultrasound devices deliver precise data to support diagnosis and patient assessment. At the same time, this discipline is highly hands-on, as proficiency typically requires extensive practical experience.
These devices are very advanced in the field of POC ultrasound. They are equipped with a rich set of AI-assisted tools, especially for cardiac imaging, which has significant application value in emergency medicine, according to Stephen Haight, an assistant professor of emergency medicine with UCSF, who also stated that, with these devices, patient care will be significantly improved. While Chinese high-end medical equipment enters the US market, US medical giants are also accelerating localized innovation in China.
In December 2025, GE Healthcare announced the opening of a new re-search and development center in North China’s Tianjin Municipality. The facility, designated the Magnetic Resonance Eastern Hemisphere Head-quarters R&D Center, serves as the company’s only system-level magnetic resonance imaging research base outside the US. “The global market is big enough, and competition between Chinese and US businesses can boost their global competitiveness,” Song Guoyou, deputy director of the Center for American Studies at Fudan University, told the Global Times. –The Daily Mail-Global Times news exchange item
